Centogene Enters Clinical Whole-Genome Sequencing Market for Rare Disease Diagnostics

Dec 08, 2016

|

Premium

NEW YORK (GenomeWeb) – German genetic diagnostics firm Centogene is betting on whole-genome sequencing for improving the interpretation of genetic variants in patients with rare genetic disorders.

Last week, the company said it installed Illumina's HiSeq X sequencing platform at its clinical laboratory in Rostock in the Northeast of Germany in order to provide diagnostic whole-genome sequencing services.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

GenomeWeb Premium gives you:
✔ Full site access
✔ Interest-based email alerts
✔ Access to archives

Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

Breaking News

The Scan

Twisting the Results

Science speaks with the University of Michigan's Jedidiah Carlson, who has tracked population genetic discussions at white nationalist sites.

Quickly, Quickly

Gene therapies could qualify for a faster US Food and Drug Administration approval process, according to Stat News.

'Right to Try' Heads Toward Law

NPR reports that the US House of Representatives has passed a bill to enable terminally ill patients access to experimental drugs.

This Week in Genome Research

In Genome Research this week: inversion variants mapped in human, non-human primate genomes; transcriptome profiling of maize, sorghum; and more.

Featured White Papers

STARLIMS Quality Manufacturing Solution Interfacing with 3rd party systems

STARLIMS Biorepository Solution Helps Fortune 200 Company Boost Efficiency, Cost Effectiveness, And Increase Sample Management By 25 Percent

ABBOTT Informatics STARLIMS Solution Helps Precision Diagnostics Achieve Compliance and Retain Customers

Meeting Modern Data Integrity and Compliance Requirements

Jun

05

Featured Webinar

Text Mining at Sanofi for Genotype-Phenotype Associations in Multiple Sclerosis

This webinar will discuss how Sanofi used literature mining to annotate the association of human leukocyte antigen (HLA) alleles with diseases and drug hypersensitivity as part of a multiple sclerosis (MS) biomarker discovery project.

Jun

12

Featured Webinar

Bridging the Gap Between Testing and Treatment in Precision Oncology

This webinar will highlight a comprehensive end-to-end solution for precision care in oncology, comprising sample acquisition through to sequencing and analysis, treatment recommendations, and follow-through.

Jun

14

Featured Webinar

Overcoming Challenges in Hematological Genomic Testing with Advanced AI

This webinar will discuss an effort underway at the University of North Carolina Medical Center's to overcome limitations in the hematological genomic testing workflow with artificial intelligence (AI) from Sophia Genetics.

Jun

19

Featured Webinar

RNA in situ Hybridization: The Next Generation of Immunohistochemistry?

This webinar will provide evidence for the use of RNA in situ hybridization (RNA ISH) as a replacement for immunohistochemistry (IHC) in cancer research and diagnostic applications.

Main menu